EUVIMED · CrossrefJournal
ESMO Rare Cancers
ISSN 3050-4619 · Elsevier BV
Latest articles
Long-term impact of sporadic desmoid fibromatosis on work life, reproductive health, and support needs: results from the PROSa-DES study
The rare cancer ‘zebra’ advantage: flipping the script for success in oncology drug development
Unusual metastatic patterns in gastrointestinal stromal tumors: a multicenter analysis from the Dutch GIST Registry
Enteric-type urachal adenocarcinoma harboring an EIF3E::RSPO2 fusion with durable response to immune checkpoint inhibition: a case report
Prolonged disease control with trabectedin in metastatic EWSR1::PATZ1 sarcoma: a case report
Durable response to bicalutamide, goserelin, and dutasteride for androgen receptor-positive metastatic salivary duct carcinoma: a case report
Enhancing the attractiveness of sarcoma drug development: from rare disease to high-value development platform
Epidemiology of sinonasal undifferentiated carcinoma in Queensland, Australia, 1982-2024: insights from a population-based cohort
A case of mucinous adenocarcinoma of the prostate: pathological complete response achieved with intensity-modulated radiation therapy
Feasibility of active surveillance for atypical lipomatous tumors and impact on quality of life: interim analysis of the MINIMALIST trial
Novel therapeutics and surrogate endpoints in chondrosarcoma: a retrospective analysis of patients enrolled in phase I/II trials
Using liver-directed therapies as backbone for combination-treatments in metastatic uveal melanoma
Palliative systemic chemotherapy in peritoneal mesothelioma: a retrospective efficacy analysis of the RENAPE database
Adding testosterone to tamoxifen in metastatic male breast cancer: the prospective, single-arm T&T pilot trial
Long-term response to relacorilant plus nab-paclitaxel in a patient with metastatic vulvar cancer: a case report
Patient preferences for surgery and systemic therapy for tenosynovial giant cell tumor: a discrete choice experiment
Precision oncology in salivary gland cancer: molecular landscape, therapeutic advances and emerging strategies
Corrigendum to ‘Sclerosing mucoepidermoid carcinoma with eosinophilia of the thyroid with molecular profiling and unusual immunoprofile: a case report’
Counting the cost: addressing financial toxicity in sarcoma
One registry, many values: trade-offs in building a rare cancers data infrastructure
Table of Contents
Editorial Board
1MO CAR T cell therapy in patients with primary central nervous system lymphoma: A LOC network study
2P A real-world analysis of H3K27-altered diffuse midline gliomas in pediatric and adult populations
4eP Artificial intelligence for diagnosis, prognosis, and treatment response in gliomas
5P PRC2 antagonism drives chemoresistance in SHH medulloblastoma
6P Anaplastic meningioma: A single-center retrospective analysis
7eP Cranial irradiation and pituitary dysfunction: A prospective study in patients with nonpituitary brain tumors
8P Expression landscape of antibody-drug conjugates in gliomas
9P Use of FGFR inhibitors for treatment of primary CNS tumors
EUVIMED